|
WO2021047584A1
|
|
SUBSTITUTED (2-AZABICYCLO [3.1.0] HEXAN-2-YL) PYRAZOLO [1, 5-a] PYRIMIDINE AND IMIDAZO [1, 2-b] PYRIDAZINE COMPOUNDS AS TRK KINASES INHIBITORS
|
|
WO2020253659A1
|
|
Heterocyclic derivatives and use thereof
|
|
WO2020239124A1
|
|
SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
|
|
WO2020063860A1
|
|
Naphthyridinone and pyridopyrimidinone compounds useful as kinases inhibitors
|
|
TW202028209A
|
|
Substituted imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine compounds as ret kinase inhibitors
|
|
WO2020063659A1
|
|
Substituted [1, 2, 4] triazolo [1, 5-a] pyridine compounds as ret kinase inhibitors
|
|
EP3774812A1
|
|
Macrocyclic compounds as trk kinases inhibitors
|
|
AU2019236892A1
|
|
Deuterated compounds as ROCK inhibitors
|
|
KR20200141035A
|
|
Substituted (2-azabicyclo [3.1.0] hexan-2-yl) pyrazolo [1, 5-a] pyrimidine and imidazo [1, 2-b] pyridazine compounds as TRK kinase inhibitors
|
